BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 17229678)

  • 21. AKAPs-PKA disruptors increase AQP2 activity independently of vasopressin in a model of nephrogenic diabetes insipidus.
    Ando F; Mori S; Yui N; Morimoto T; Nomura N; Sohara E; Rai T; Sasaki S; Kondo Y; Kagechika H; Uchida S
    Nat Commun; 2018 Apr; 9(1):1411. PubMed ID: 29650969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New autosomal recessive mutations in aquaporin-2 causing nephrogenic diabetes insipidus through deficient targeting display normal expression in Xenopus oocytes.
    Leduc-Nadeau A; Lussier Y; Arthus MF; Lonergan M; Martinez-Aguayo A; Riveira-Munoz E; Devuyst O; Bissonnette P; Bichet DG
    J Physiol; 2010 Jun; 588(Pt 12):2205-18. PubMed ID: 20403973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methyl-beta-cyclodextrin induces vasopressin-independent apical accumulation of aquaporin-2 in the isolated, perfused rat kidney.
    Russo LM; McKee M; Brown D
    Am J Physiol Renal Physiol; 2006 Jul; 291(1):F246-53. PubMed ID: 16449354
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Missorting of the Aquaporin-2 mutant E258K to multivesicular bodies/lysosomes in dominant NDI is associated with its monoubiquitination and increased phosphorylation by PKC but is due to the loss of E258.
    Kamsteeg EJ; Savelkoul PJ; Hendriks G; Konings IB; Nivillac NM; Lagendijk AK; van der Sluijs P; Deen PM
    Pflugers Arch; 2008 Mar; 455(6):1041-54. PubMed ID: 17965877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disruption of prostaglandin E2 receptor EP4 impairs urinary concentration via decreasing aquaporin 2 in renal collecting ducts.
    Gao M; Cao R; Du S; Jia X; Zheng S; Huang S; Han Q; Liu J; Zhang X; Miao Y; Kang J; Gustafsson JÅ; Guan Y
    Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8397-402. PubMed ID: 26100911
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lithium-induced nephrogenic diabetes insipidus: renal effects of amiloride.
    Bedford JJ; Weggery S; Ellis G; McDonald FJ; Joyce PR; Leader JP; Walker RJ
    Clin J Am Soc Nephrol; 2008 Sep; 3(5):1324-31. PubMed ID: 18596116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The contribution of collecting duct NOS1 to the concentrating mechanisms in male and female mice.
    Mendoza LD; Hyndman KA
    Am J Physiol Renal Physiol; 2019 Sep; 317(3):F547-F559. PubMed ID: 31241990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Wnt5a induces renal AQP2 expression by activating calcineurin signalling pathway.
    Ando F; Sohara E; Morimoto T; Yui N; Nomura N; Kikuchi E; Takahashi D; Mori T; Vandewalle A; Rai T; Sasaki S; Kondo Y; Uchida S
    Nat Commun; 2016 Nov; 7():13636. PubMed ID: 27892464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liver X receptor β increases aquaporin 2 protein level via a posttranscriptional mechanism in renal collecting ducts.
    Su W; Huang SZ; Gao M; Kong XM; Gustafsson JÅ; Xu SJ; Wang B; Zheng F; Chen LH; Wang NP; Guan YF; Zhang XY
    Am J Physiol Renal Physiol; 2017 Apr; 312(4):F619-F628. PubMed ID: 28052875
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Congenital nephrogenic diabetes insipidus: what can we learn from mouse models?
    Boone M; Deen PM
    Exp Physiol; 2009 Feb; 94(2):186-90. PubMed ID: 18790812
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hereditary Nephrogenic Diabetes Insipidus: Pathophysiology and Possible Treatment. An Update.
    Milano S; Carmosino M; Gerbino A; Svelto M; Procino G
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29125546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Repulsion between Lys258 and upstream arginines explains the missorting of the AQP2 mutant p.Glu258Lys in nephrogenic diabetes insipidus.
    Kamsteeg EJ; Stoffels M; Tamma G; Konings IB; Deen PM
    Hum Mutat; 2009 Oct; 30(10):1387-96. PubMed ID: 19701945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of aquaporin-2 trafficking.
    Nedvetsky PI; Tamma G; Beulshausen S; Valenti G; Rosenthal W; Klussmann E
    Handb Exp Pharmacol; 2009; (190):133-57. PubMed ID: 19096775
    [TBL] [Abstract][Full Text] [Related]  

  • 34. AQP2: Mutations Associated with Congenital Nephrogenic Diabetes Insipidus and Regulation by Post-Translational Modifications and Protein-Protein Interactions.
    Gao C; Higgins PJ; Zhang W
    Cells; 2020 Sep; 9(10):. PubMed ID: 32993088
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vasopressin increases S261 phosphorylation in AQP2-P262L, a mutant in recessive nephrogenic diabetes insipidus.
    Trimpert C; van den Berg DT; Fenton RA; Klussmann E; Deen PM
    Nephrol Dial Transplant; 2012 Dec; 27(12):4389-97. PubMed ID: 22778181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An impaired routing of wild-type aquaporin-2 after tetramerization with an aquaporin-2 mutant explains dominant nephrogenic diabetes insipidus.
    Kamsteeg EJ; Wormhoudt TA; Rijss JP; van Os CH; Deen PM
    EMBO J; 1999 May; 18(9):2394-400. PubMed ID: 10228154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and characterization of aquaporin-2 water channel mutations causing nephrogenic diabetes insipidus with partial vasopressin response.
    Canfield MC; Tamarappoo BK; Moses AM; Verkman AS; Holtzman EJ
    Hum Mol Genet; 1997 Oct; 6(11):1865-71. PubMed ID: 9302264
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An aquaporin-2 water channel mutant which causes autosomal dominant nephrogenic diabetes insipidus is retained in the Golgi complex.
    Mulders SM; Bichet DG; Rijss JP; Kamsteeg EJ; Arthus MF; Lonergan M; Fujiwara M; Morgan K; Leijendekker R; van der Sluijs P; van Os CH; Deen PM
    J Clin Invest; 1998 Jul; 102(1):57-66. PubMed ID: 9649557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. V2R mutations and nephrogenic diabetes insipidus.
    Bichet DG
    Prog Mol Biol Transl Sci; 2009; 89():15-29. PubMed ID: 20374732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell-biologic and functional analyses of five new Aquaporin-2 missense mutations that cause recessive nephrogenic diabetes insipidus.
    Marr N; Bichet DG; Hoefs S; Savelkoul PJ; Konings IB; De Mattia F; Graat MP; Arthus MF; Lonergan M; Fujiwara TM; Knoers NV; Landau D; Balfe WJ; Oksche A; Rosenthal W; Müller D; Van Os CH; Deen PM
    J Am Soc Nephrol; 2002 Sep; 13(9):2267-77. PubMed ID: 12191971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.